Willkie Farr & Gallagher advised Third Point, Schulte Roth & Zabel advised Birch Grove, and Weil, Gotshal & Manges advised American Securities on the deal. AS...
Third Point’s Acquisition of AS Birch Grove
Ginkgo Bioworks’ Acquisition of StrideBio’s Gene Therapy Assets
Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...